For the seventh consecutive year, Finnegan received top rankings in the 2018 LMG Life Sciences Rankings. The firm was “highly recommended” in the categories of Patent Prosecution, Patent Strategy & Management, General Patent Litigation, and Hatch-Waxman Patent Litigation. In addition, the following attorneys were ranked as LMG Life Sciences Stars:
- Michele C. Bosch - Intellectual Property, General Patent Litigation, Patent Strategy & Management
- Bryan C. Diner - Intellectual Property, Hatch-Waxman Patent Litigation, Patent Strategy & Management
- Donald R. Dunner - Intellectual Property, General Patent Litigation
- Thomas L. Irving - Patent Prosecution, Patent Strategy & Management
- J. Michael Jakes - General Patent Litigation, Patent Strategy and Management
- Howard W. Levine - General Patent Litigation
- Charles E. Lipsey - General Patent Litigation, Hatch-Waxman Patent Litigation (Branded)
- Jill K. MacAlpine - General Patent Litigation, Patent Strategy & Management
- Leslie A. McDonell - Patent Prosecution, Patent Strategy & Management
- James B. Monroe - Intellectual Property, General Patent Litigation
- Sanya Sukduang - General Patent Litigation, Hatch-Waxman Patent Litigation, Patent Strategy & Management,
Earlier this year, the firm took home “Intellectual Property Boutique Firm of the Year” and “Inter-Partes Review Firm of the Year” at the 2018 LMG Life Sciences Awards. Partner Charles Lipsey was named “Hatch-Waxman Litigator of the Year—Branded.”
About Finnegan
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the largest IP law firms in the world. From offices in Atlanta, Boston, London, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo, and Washington, DC, the firm practices all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to European patents and trade marks, international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com. Follow us on LinkedIn and Twitter.
